AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
12min chapter
Novo Nordisk (Ozempic)
Acquired
The Search for an Oral Anti-Diabetic Drug
This chapter discusses Novo Nordisk's search for a viable oral anti-diabetic drug, highlighting the challenges faced and the research done by Lata Biera-Nuzen. It explains the concept of glucagon-like peptide one (GLP one) and the potential it holds in treating type two diabetes. The chapter also explores the development of GLP one analog drugs and the role of clinical trials in bringing new drugs to market.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode